BlueWillow Biologics is a clinical-stage, biopharmaceutical company focused on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. The platform employs novel oil-in-water nanodroplets for products administered to the skin and nose. NanoBio Protect demonstrates broad-spectrum anti-bacterial and anti-viral activity in laboratory tests, including inactivation of enveloped viruses. NanoBio Protect is an important additive measure to hand washing and social distancing, in an effort to help reduce the risk of infection in healthcare workers and others on the front lines of the COVID-19 outbreak.